Chowdhury Enayet K, Langham Robyn G, Owen Alice, Krum Henry, Wing Lindon M H, Nelson Mark R, Reid Christopher M
Department of Epidemiology & Preventive Medicine, Monash University, Victoria, Australia;
Department of Nephrology and University of Melbourne Department of Medicine, St. Vincent's Hospital, Melbourne, Australia;
Am J Hypertens. 2015 Mar;28(3):380-6. doi: 10.1093/ajh/hpu160. Epub 2014 Sep 18.
The Modifications of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) are 2 equations commonly used to estimate glomerular filtration rate (eGFR). The predictive performance offered by these equations, particularly in relation to clinical outcomes in elderly hypertensive patients, is not clear.
The Second Australian National Blood Pressure Study cohort was used to investigate the predictive performance of these 2 equations for long-term outcomes (median 10.8 years) in elderly treated hypertensive patients. Both equations were used to calculate eGFR in 6,083 patients aged ≥65 years and classified as having chronic kidney disease (CKD) or no CKD (eGFR ≥60ml/min/1.73 m2).
More patients were classified as having no CKD using the CKD-EPI equation compared with the MDRD equation (72.1% vs. 69.4%; P = 0.001). Both equations performed similarly in risk prediction of all-cause and cardiovascular mortality with decreased eGFR, except for patients with baseline eGFR of 45-59ml/min/1.73 m2, where the CKD-EPI equation predicted higher risk of all-cause mortality compared with those with no CKD. However, the magnitude of difference in risk prediction was too small to be clinically meaningful. Both equations showed similar predictive performance. However, we observed longer survival and no higher risk in those who were reclassified as having no CKD using the CKD-EPI equation, but these patients were classified earlier as having CKD using the MDRD equation.
There was no clinically relevant difference in predictive performance for long-term survival by eGFR calculated using either of these equations in this elderly hypertensive population.
肾脏疾病饮食改良(MDRD)公式和慢性肾脏病流行病学协作组(CKD-EPI)公式是常用于估算肾小球滤过率(eGFR)的两个公式。这些公式的预测性能,尤其是与老年高血压患者临床结局的关系尚不清楚。
利用澳大利亚第二次全国血压研究队列,调查这两个公式对老年高血压患者长期结局(中位时间10.8年)的预测性能。两个公式均用于计算6083例年龄≥65岁且被分类为患有慢性肾脏病(CKD)或无CKD(eGFR≥60ml/(min·1.73m²))的患者的eGFR。
与MDRD公式相比,使用CKD-EPI公式分类为无CKD的患者更多(72.1%对69.4%;P=0.001)。在全因死亡率和心血管死亡率的风险预测方面,随着eGFR降低,两个公式的表现相似,但对于基线eGFR为45-59ml/(min·1.73m²)的患者,与无CKD的患者相比,CKD-EPI公式预测的全因死亡风险更高。然而,风险预测的差异幅度太小,不具有临床意义。两个公式显示出相似的预测性能。但是,我们观察到,使用CKD-EPI公式重新分类为无CKD的患者生存期更长且风险未增加,但这些患者使用MDRD公式更早被分类为患有CKD。
在这个老年高血压人群中,使用这两个公式计算的eGFR对长期生存的预测性能在临床上没有显著差异。